Angion Biomedica (ANGN) – Management Comments
-
Angeion Corp (ANGN) and Vifor Pharma Report Complete Enrollment in Phase 2 Study of ANG-3777 for Cardiac-Surgery Associated Acute Kidney Injury
-
Angeion Corp (ANGN) Reports Complete Enrollment in Phase 2 Study of ANG-3777 for Acute Lung Injury in Patients with COVID-19 Associated Pneumonia
Back to ANGN Stock Lookup